| Name | Oxford Cannabinoid Technologies Holdings |
|---|---|
| Epic | OCTP |
| Isin | GB00BMVMRB86 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.12p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £1.25 | Debt ratio | n/a |
| Shares in issue | 1,088.42 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -180.24 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.62 | 52-week high / low | 0.12p / 1.30p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Oxford Cannabinoid Technologies Holdings |
|---|---|
| Address | Prama House, 267 Banbury Road, Oxford, United Kingdom, OX2 7HT |
| Telephone | +44 (0) 203 034 2820 |
| Website | http://www.oxcantech.com/ |
| Director | Position |
|---|---|
| Ms Clarissa Ann Sowemimo- Coke | CEO |
| Mr Indraneil (Neil) Mahapatra | Non-Executive Director |
| Mr Tim Corn | Executive Director |
| Mrs Julie Patricia Pomeroy | Non-Executive Chairman |
| Mr Paul William Smalley | Group Finance Director |
| Mr Lord Mott OBE | Independent Non-Executive Director |
| Mr Charanjit (Cheryl) Dhillon | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 30/04/23 | 30/04/22 | 31/05/21 |
| Intangible asssets and goodwill | 0.01 | 0.05 | 0.1 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 0.01 | 0.05 | 0.16 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 2.19 | 2.61 | 0.42 |
| Cash and equivalents | 2.3 | 9.17 | 14.63 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 4.5 | 11.82 | 15.21 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.58 | 2.03 | 0.95 |
| Long term liabilities | n/a | n/a | 0.05 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.58 | 2.03 | 1 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 3.91 | 9.79 | 14.21 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 9.6 | 9.6 | 9.6 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -19.73 | -13.78 | -9.07 |
| Share premium account | 11.88 | 11.88 | 11.88 |
| Total equity | 3.91 | 9.79 | 14.21 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -7.04 | -5.5 | -3.35 |
| Pre-tax profit | -7.03 | -5.5 | -3.37 |